These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 17855

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Continuous intravenous antiarrhythmic agents in the intensive care unit: strategies for safe and effective use of amiodarone, lidocaine, and procainamide.
    Samarin MJ, Mohrien KM, Oliphant CS.
    Crit Care Nurs Q; 2015; 38(4):329-44. PubMed ID: 26335213
    [Abstract] [Full Text] [Related]

  • 46. The treatment of ventricular rhythm disturbances.
    Somberg JC, Miura D, Keefe DL.
    Am Heart J; 1986 Jun; 111(6):1162-76. PubMed ID: 2424297
    [No Abstract] [Full Text] [Related]

  • 47. [Drug therapy of tachyarrhythmias (author's transl)].
    Theisen K.
    Klin Wochenschr; 1978 Feb 15; 56(4):153-68. PubMed ID: 24134
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT, Spann JF, Zelis R, Amsterdam EA.
    Clin Pharmacol Ther; 1970 Feb 15; 11(4):460-80. PubMed ID: 4913865
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Out patient prophylaxis of arrhythmias due to coronary insufficiency (author's transl)].
    Laurencet FL.
    Schweiz Rundsch Med Prax; 1976 Jan 20; 65(3):67-9. PubMed ID: 3777
    [No Abstract] [Full Text] [Related]

  • 52. Treatment of cardiac arrhythmias. Part II--The drugs.
    Med Lett Drugs Ther; 1978 Dec 29; 20(26):116-20. PubMed ID: 723778
    [No Abstract] [Full Text] [Related]

  • 53. ["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
    Brochier M, Fauchier JP.
    Arch Mal Coeur Vaiss; 1978 Apr 29; 71(4):477-88. PubMed ID: 78692
    [Abstract] [Full Text] [Related]

  • 54. [Possibilities of drug therapy of arrhythmias in myocardial infarct].
    Kozená J, Kolár J.
    Cas Lek Cesk; 1971 May 29; 110(19):437-41. PubMed ID: 5574742
    [No Abstract] [Full Text] [Related]

  • 55. Series on pharmacology in practice. 2. Antiarrhythmic drug therapy.
    Federman J, Vlietstra RE.
    Mayo Clin Proc; 1979 Aug 29; 54(8):531-42. PubMed ID: 459565
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [New aspects concerning drug therapy of arrhythmia].
    Merx W.
    Med Welt; 1975 Aug 29; 6(35):1503-8. PubMed ID: 240999
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.